Displaying 20 results from an estimated 400 matches similar to: "[OT] Survival and Function as co-primary endpoints in clinical trials. How to simulate in R ?"
2008 Oct 09
1
Error when reading a SAS transport file
Dear All,
I get the following error when using either SASxport or Hmisc to read an
.xpt file:
> w <- read.xport("D:/consult/Trophos/dnp/base/TRO_ds_20081006.xpt")
Erreur dans factor(x, f$value, f$label) :
invalid labels; length 15 should be 1 or 14
> z<- sasxport.get("D:/consult/Trophos/dnp/base/TRO_ds_20081006.xpt")
Erreur dans factor(x, f$value, f$label) :
2008 Sep 29
0
Script for dose proportionality assessment using power model and confidence interval criteria
Dear R-Helpers
Has anyone written a script for the dose proportionality assessement
using the power model and the confidence interval criteria as described
in
- Gough at al. Assessment of dose proportionality: report from the
statisticians in the pharmaceutical industry in Drug Information
Journal,1995, 29:1039-1048 and/or
- Smith et al. Confidence interval criteria for assessment of dose
2006 Feb 26
1
assigning differences in a loop
Dear All
I would need to generate differences between variates such as
nam1<-nam2-nam3 in the following loop:
for(i in c("13","26","38")) {
for (j in c("HR","PQ","QRS","QT")){
nam1<-paste("d",j,i,sep="")
nam2<-paste(j,i,sep=".")
2002 Sep 13
0
Sample size for factorial clinical trials with survival endpoints
Dear All,
I am looking an R version of the "Computer program for sample size and
power calculations in the design of multi-arm and factorial clinical trials
with survival endpoints".
Best regards,
Giovanni Parrinello
P.S.: in the meantime I am preparing a summary for my preceeding question
about time-varying covariates in the Cox model and
I thank Frank Harrell, Chuck Cleland,
2010 Feb 19
1
BMDP and SAS (was R in clinical trials)
I used both BMDP and SAS in my earlier years, side by side. At that
time the BMDP statistical methods were much more mature and
comprehensive: we treated them as the standard when the two packages
disagreed. (It was a BMDP manual that clearly explained to me what the
hypothesis of "Yate's weighted mean test" is, something SAS decided to
call "type III" and eternally
2010 Apr 27
1
Randomization for block random clinical trials
Hi,
I’m new to R (just installed today) and I’m trying to figure out how to do
stratified randomisation using it. My google search expedition has lead me
to believe that blockrand package will most probably be the answer to it.
I’ve played around with blockrand for awhile and tried the sample code:
library(blockrand)
##stratified by sex
male <- blockrand(n=100,
2000 Feb 14
1
Question about permissions and roaming profiles
Hi,
Just a short question : Is it possible to NOT have the profiles
directory used for the roaming profiles shares ([profiles]) in unix mode
777 ? Because it is a bit annoying when unix users have access to the
samba server providing a 777 space ?
Thanks in advance,
--
G?rard MILHAUD
?cole Sup?rieure d'Ing?nieurs de Luminy (ESIL)
Luminy - Case 925 - 13288 Marseille Cedex 09
T?l.: 04
2008 Oct 30
2
Inno setup script request
Dear all,
I am a public resaerch engineer in marseille (France) and I am currently developping a free software for high throughput experiments in biology using mainly R (bioconductor). This project is almost at a finalisation stage and I would like to build an installshield using innosetup for the windows version of my software. The ideal case would be to also include the required 2.6
2009 Jan 11
2
R, clinical trials and the FDA
I hope that Marc doesn't mind, but I felt that part of his recent post
was important enough to deserve it's own subject line rather then
being lost in a 60-msg-long thread...
On Sun, Jan 11, 2009 at 10:08 AM, Marc Schwartz
<marc_schwartz at comcast.net> wrote:
...
I strongly believe that the comments regarding R and the FDA are overly
negative and pessimistic.
The hurdles to
2009 Dec 17
2
SPLUS Seqtrial vs. R Packages for sequential clinical trials designs
Hello Everyone,
I’m a SAS user who has recently become interested in sequential clinical trials designs. I’ve discovered that the SAS based approaches for these designs are either too costly or are “experimental.” So now I’m looking for alternative software. Two programs that seem promising are SPLUS Seqtrial and R.
I recently obtained a 30 day trial for the SPLUS Seqtrial add-on and have
2006 Mar 31
0
get_md4pw: Workstation PC-WINSIC$: no account in domain
hello to all
i use a samba server (3.0.14a) PDC which makes the users and computers
authentication on a LDAP server (openldap on debian sarge) (people
branch and computers branch)..
does somebody had this problem? when a user connects from a PC which is
in a windows domain, the authentication doesn't succeed for the
following reason
the error message is (translated from french message
2003 May 16
1
make buildworld fails when upgrading to 4.8 stable : SUITE
OK, It works if I modify my make.conf to not build openss[lh] like it :
#MAKE_KERBEROS5= yes
# TEST
NO_OPENSSH= true # do not build OpenSSH
NO_OPENSSL= true # do not build OpenSSL (implies NO_OPENSSH)
Maybe I install openss[hl] as ports after... But I'm not satisfied with
this way...
--
G?rard MILHAUD
?cole Sup?rieure d'Ing?nieurs de Luminy (ESIL)
Luminy - Case 925 -
2003 May 16
1
Help please : make buildworld fails when upgrading to 4.8 stable
Hi,
I can't build the world. I have an error in SSL, with today cvs
sources. Here is the error :
/usr/src/secure/lib/libssl/../../../crypto/openssl/ssl/bio_ssl.c: In
function `ssl_read':
/usr/src/secure/lib/libssl/../../../crypto/openssl/ssl/bio_ssl.c:209:
`SSL_ERROR_WANT_ACCEPT' undeclared (first use in this function)
2008 Apr 09
1
read table not reading lines containing single quotes
Hi,
* I am using read.table command as follow
kegg<-read.table("c:/IDs.tab",header =TRUE,quote= "'", sep="\t") *
Fragment of file is as follow:
ID Pathway
04916 Melanogenesis
04920 Adipocytokine signaling pathway
04930 Type II diabetes mellitus
04940 Type I diabetes mellitus
04950 Maturity onset diabetes of the young
05010
2003 Dec 04
4
regression with limited range response
Dear R experts
How can you perform a regression analysis in R when the dependent
variable is countiuous but bounded, say between 0 and 100?
I would be grateful for pointers to R-functions but also for hints to
relavant litterature since I have never worked with this problem before.
Thanks in advance.
Kim Mouridsen.
[[alternative HTML version deleted]]
2010 Jan 05
0
James Matthews wants to connect on LinkedIn
LinkedIn
------------
James Matthews requested to add you as a connection on LinkedIn:
------------------------------------------
Romeo,
I'd like to add you to my professional network on LinkedIn.
- James Matthews
Accept invitation from James Matthews
2010 Feb 17
8
Use of R in clinical trials
Dear all,
There have been a variety of discussions on the R list regarding the use of R in clinical trials. The following post from the STATA list provides an interesting opinion regarding why SAS remains so popular in this arena: http://www.stata.com/statalist/archive/2008-01/msg00098.html
Regards,
-Cody Hamilton
2009 Mar 29
0
[LLVMdev] GSoC 2009 application
On Sun, Mar 29, 2009 at 3:33 PM, Benoit Boissinot
<bboissin+llvm at gmail.com> wrote:
> While it is not described in the litterature, I don't think you need
> to introduce a new
> function:
> x0 = ...
> x1, x2 = \sigma (x0)
> |
> +----+------+
> | |
> v v
> ... = x1 ... = x2
>
> Can be transformed to:
>
2012 Jun 27
1
Make a reference?
How can I make a reference i this case? I want to make a reference to
'Artikel XXX'
For example
In The Artikel 'XXXX' there is two tables.
..
Litterature
Artikel XXX
--
View this message in context: http://r.789695.n4.nabble.com/Make-a-reference-tp4634611.html
Sent from the R help mailing list archive at Nabble.com.
2018 Jan 13
1
Clinical Trial data sets in public domain?
Is anybody using R to do analysis of clinical trial datasets that have been
put in the public domain (which are super hard to find). Not only a single
data table, but the actual database, with a handful of data tables with
one-to-one or many-to-one relationships?
[ For example, "Adverse Events" and "Patient Info" are two datasets with a
many-to-one relationship, the